Bg pattern

ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

AlmotriptanKern Pharma12.5 mg film-coated tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Almotriptan Kern Pharma and what is it used for
  2. What you need to know before you take Almotriptan Kern Pharma
  3. How to take Almotriptan Kern Pharma
  4. Possible side effects
  5. Storage of Almotriptan Kern Pharma
  6. Contents of the pack and further information

1. What is Almotriptan Kern Pharma and what is it used for

Almotriptan Kern Pharma is an antimigraine drug that belongs to a class of compounds known as selective serotonin receptor agonists. It is believed that Almotriptan Kern Pharma reduces the inflammatory response associated with migraines by binding to serotonin receptors in cerebral blood vessels (cranial), causing vasoconstriction.

Almotriptan Kern Pharma is used to relieve headache pain associated with migraine attacks with or without aura.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Almotriptan Kern Pharma

Do not take AlmotriptanKernPharma

  • if you are allergic to almotriptan or any of the other ingredients of this medicine (listed in section 6).
  • if you have or have ever had any disease that limits blood flow to the heart, such as:
    • myocardial infarction,
    • chest pain or discomfort that occurs normally after physical activity or stress,
    • painless cardiac problems,
    • chest pain that occurs at rest,
    • severe hypertension (very high blood pressure),
    • uncontrolled, mild or moderate hypertension.
  • if you have had a stroke or a reduction in cerebral blood flow,
  • if you have had an obstruction of the large arteries of the arms or legs (peripheral vascular disease),
  • if you are taking other medicines for migraine, including ergotamine, dihydroergotamine and methysergide or another selective serotonin agonist (e.g. sumatriptan),
  • if you have severeliver disease

Warnings and precautions

Consult your doctor or pharmacist before starting to take Almotriptan Kern Pharma:

  • if your type of migraine has not been diagnosed,
  • if you are allergic to antibacterial medicines used to treat urinary tract infections (sulfonamides),
  • if the symptoms of your headache are different from those of your usual migraine attacks, for example, you hear noise in your ears or feel dizzy, you have a brief paralysis of a part of your body or paralysis of the muscles that control your eye movements, or any other new symptom,
  • if you are at risk of having heart disease, including high blood pressure and uncontrolled, high cholesterol, obesity, diabetes, are a smoker, have a family history of heart disease, are a postmenopausal woman or are a man over 40 years old,
  • if you have mild or moderate liver disease,
  • if you have severekidney disease,
  • if you are over 65 years old, as you are more likely to experience increases in blood pressure,
  • if you are taking antidepressant ISRS (selective serotonin reuptake inhibitors) or IRSN (serotonin and norepinephrine reuptake inhibitors). See also below, Taking Almotriptan Kern Pharma with other medicines.

It has been suggested that excessive use of antimigraine medicines may lead to chronic headache.

Children and adolescents

Children under 18 years old should not take Almotriptan Kern Pharma.

Over 65 years of age

If you are over 65 years old, you should consult your doctor before taking this medicine.

Taking AlmotriptanKernPharmawith other medicines

Tell your doctor or pharmacist if you are using or have recently used or may need to use any other medicine.

Please inform your doctor:

  • if you are taking any medicine for depression, such as monoamine oxidase inhibitors (e.g. moclobemide), selective serotonin reuptake inhibitors (e.g. fluoxetine) or serotonin and norepinephrine reuptake inhibitors (e.g. venlafaxine), as these medicines may cause serotonin syndrome, a potentially very serious reaction to treatment. The symptoms of serotonin syndrome include: confusion, agitation, fever, sweating, uncoordinated movements of the limbs or eyes, uncontrolled muscle movements or diarrhea,
  • if you are taking St. John's Wort preparations (Hypericum perforatum), as it may increase the likelihood of experiencing side effects.

Almotriptan should not be taken at the same time as other medicines that contain ergotamine, which are also used to treat migraine. However, both medicines can be taken one after the other, provided that a minimum amount of time has passed between doses:

  • after taking almotriptan, it is recommended to wait at least 6 hours before taking ergotamine,
  • after taking ergotamine, it is recommended to wait at least 24 hours before taking Almotriptan.

AlmotriptanKern Pharmawith food and drink

Almotriptan Kern Pharma can be taken with or without food.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

There is only limited information available on the use of almotriptan during pregnancy. Almotriptan Kern Pharma should only be used during pregnancy if prescribed by your doctor and only after carefully considering the balance of benefits and risks.

Cautious use is required when using this medicine during breastfeeding. You should avoid breastfeeding during the 24 hours following treatment.

Driving and using machines

This medicine, like migraine, can cause drowsiness. If you experience these effects, avoid driving or using machines, as it can be dangerous.

3. How to take Almotriptan Kern Pharma

Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.

Almotriptan Kern Pharma should only be used to treat a migraine attack that has already occurred and not to prevent migraine attacks or headaches.

Adults (18-65 years)

The recommended dose is one Almotriptan Kern Pharma tablet (12.5 mg of almotriptan) that should be taken as soon as possible after the onset of a migraine attack. If the attack does not subside, do not take more than one tablet.

If you experience a second attack within the next 24 hours, you can take a second 12.5 mg tablet, but always provided that at least 2 hours have passed between the first and second tablet.

The maximum daily dose is two 12.5 mg tablets in 24 hours.

The tablets can be taken with liquid (e.g. water) and can be taken with or without food.

Almotriptan Kern Pharma should be taken as soon as possible after the onset of a migraine attack, although it is also effective if taken later.

Severe kidney disease

If you have severe kidney disease, do not take more than one 12.5 mg tablet in 24 hours.

If you take more AlmotriptanKernPharmathan you should

If you accidentally take too many Almotriptan Kern Pharma tablets, or if someone else or a child takes this medicine, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 915 620 420, indicating the medicine and the amount ingested.

If you forget to take AlmotriptanKernPharma

Try to take Almotriptan Kern Pharma as prescribed. Do not take a double dose to make up for forgotten doses.

If you have any doubts about the use of Almotriptan Kern Pharma, consult your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Frequent(may affect up to 1 in 10 people)

  • dizziness
  • drowsiness
  • nausea
  • vomiting
  • fatigue

Uncommon(may affect up to 1 in 100 people)

  • tingling, itching or numbness of the skin (paresthesia)
  • headache
  • ringing, noise, clicking (tinnitus)
  • strong heartbeat (palpitations)
  • throat tightness
  • diarrhea
  • indigestion
  • dry mouth
  • muscle pain (myalgia)
  • bone pain
  • chest pain
  • feeling of weakness (asthenia)

Very rare(may affect up to 1 in 10,000 people)

  • coronary artery spasm (coronary vasospasm)
  • heart attack (myocardial infarction)
  • increased heart rate (tachycardia)

Frequency not known(cannot be estimated from the available data)

  • seizures

Tell your doctor immediately if you experience:

Chest pain, tightness in the chest or throat, or any other symptom that may suggest a heart attack. Please inform your doctor immediately and do not take any further Almotriptan Kern Pharma tablets.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines (Website: www.notificaRAM.es).

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Almotriptan Kern Pharma

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of AlmotriptanKern Pharma12.5 mg film-coated tablets

  • The active substance is almotriptan. Each film-coated tablet contains 12.5 mg of almotriptan (as almotriptan malate).
  • The other ingredients of the tablet are: Tablet core: mannitol (E-421), microcrystalline cellulose, povidone, sodium starch glycolate and sodium stearyl fumarate. Tablet coating: hypromellose, titanium dioxide (E-171), macrogol 400 and talc.

Appearance and packaging

Almotriptan Kern Pharma 12.5 mg film-coated tablets are available in packs of 4 and 6 tablets.

White, circular, biconvex film-coated tablets.

Marketing authorisation holder

Kern Pharma, S.L.

Polígono Ind. Colón II. Venus 72

08228 Terrassa (Barcelona)

Manufacturer

LABORATORIOS NORMON, S.A.

Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)

Date of last revision of this leaflet:June 2013

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS

Discuss questions about ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS?
ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS?
The active ingredient in ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS is almotriptan. This information helps identify medicines with the same composition but different brand names.
How much does ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS is around 19.53 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS?
ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS?
Other medicines with the same active substance (almotriptan) include ALMOGRAN 12.5 mg FILM-COATED TABLETS, ALMOTRIPTAN CINFA 12.5 mg FILM-COATED TABLETS, ALMOTRIPTAN COMBIX 12.5 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media